116.60 -0.02 (-0.02%)
After hours: 7:37PM EST
Previous Close | 130.00 |
Open | 125.38 |
Bid | 112.00 x 900 |
Ask | 124.00 x 1000 |
Day's Range | 113.76 - 131.91 |
52 Week Range | 18.52 - 214.07 |
Volume | 1,540,980 |
Avg. Volume | 890,461 |
Market Cap | 5.673B |
Beta (5Y Monthly) | 0.76 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.76 |
Earnings Date | Feb 04, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 153.75 |
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Watchmaker Genomics today announced a broad partnership to enable innovative research across a wide range of high throughput sequencing applications including oncology and tumor profiling, inherited disease detection, liquid biopsy assays, and minimal residual disease monitoring.
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced several events at the virtual 2021 Advances in Genome Biology and Technology (AGBT) meeting to be held March 1-3, 2021.
Twist Bioscience Corp (NASDAQ: TWST) has launched its NGS Methylation Detection System, end-to-end sample preparation, and target enrichment solution for identifying methylated regions in the human genome. DNA methylation plays a key role in many biological processes, including cancer. A methyl group can alter genetic behavior without changing the DNA sequence when present on a single nucleotide. In cancer methylation, patterns appear early, providing an approach for screening through liquid biopsy tests designed to detect a wide range of tumors from a single blood sample. Also, Twist has partnered with New England Biolabs (NEB), which have developed an enzyme-based alternative to sodium bisulfite treatment, EM-seqTM, for the preparation of samples for methylation analysis. Earlier this week, Twist Bioscience and China's Berry Genomics announced a partnership on next-generation sequencing target enrichment and library preparation tools. Price Action: TWST is up 2.02% at $138.02 in market trading hours on the last check Wednesday. See more from BenzingaClick here for options trades from BenzingaTwist Bioscience Collaborates With Australia Based Specialist Provider For Whole Exome Capture Assay© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.